» Authors » Marie Samanovic

Marie Samanovic

Explore the profile of Marie Samanovic including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 11
Citations 393
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Blank R, Haberman R, Qian K, Samanovic M, Castillo R, Jimenez Hernandez A, et al.
Rheumatology (Oxford) . 2022 May; 62(1):467-472. PMID: 35640110
Objectives: Autoantibody seroconversion has been extensively studied in the context of COVID-19 infection but data regarding post-vaccination autoantibody production is lacking. Here we aimed to determine the incidence of common...
2.
Pant J, Samanovic M, Nelson M, Keceli M, Verdi J, Beverley S, et al.
PLoS Pathog . 2021 Sep; 17(9):e1008768. PMID: 34559857
Trypanosome Lytic Factor (TLF) is a primate-specific high-density lipoprotein (HDL) complex that, through the cation channel-forming protein apolipoprotein L-1 (APOL1), provides innate immunity to select kinetoplastid parasites. The immunoprotective effects...
3.
Izmirly P, Kim M, Samanovic M, Fernandez-Ruiz R, Ohana S, Deonaraine K, et al.
Arthritis Rheumatol . 2021 Aug; 74(2):284-294. PMID: 34347939
Objective: To evaluate seroreactivity and disease flares after COVID-19 vaccination in a multiethnic/multiracial cohort of patients with systemic lupus erythematosus (SLE). Methods: Ninety SLE patients and 20 healthy controls receiving...
4.
Maiti G, Frikeche J, Lam C, Biswas A, Shinde V, Samanovic M, et al.
Proc Natl Acad Sci U S A . 2021 Jul; 118(27). PMID: 34215697
Infections and inflammation are profoundly influenced by the extracellular matrix (ECM), but their molecular underpinnings are ill defined. Here, we demonstrate that lumican, an ECM protein normally associated with collagens,...
5.
Haberman R, Herati R, Simon D, Samanovic M, Blank R, Tuen M, et al.
Ann Rheum Dis . 2021 May; 80(10):1339-1344. PMID: 34035003
Objective: To investigate the humoral and cellular immune response to messenger RNA (mRNA) COVID-19 vaccines in patients with immune-mediated inflammatory diseases (IMIDs) on immunomodulatory treatment. Methods: Established patients at New...
6.
Haberman R, Herati R, Simon D, Samanovic M, Blank R, Tuen M, et al.
medRxiv . 2021 May; PMID: 34013285
Objective: To investigate the humoral and cellular immune response to mRNA COVID-19 vaccines in patients with immune-mediated inflammatory diseases (IMIDs) on immunomodulatory treatment. Methods: Established patients at NYU Langone Health...
7.
Jones B, Brown-Augsburger P, Corbett K, Westendorf K, Davies J, Cujec T, et al.
bioRxiv . 2020 Oct; PMID: 33024963
One Sentence Summary: LY-CoV555, an anti-spike antibody derived from a convalescent COVID-19 patient, potently neutralizes SARS-CoV-2 and protects the upper and lower airways of non-human primates against SARS-CoV-2 infection.
8.
Thomson R, Samanovic M, Raper J
Future Microbiol . 2009 Sep; 4(7):789-96. PMID: 19722834
Trypanosome lytic factors (TLFs) are high-density lipoproteins and components of primate innate immunity. TLFs are characterized by their ability to kill extracellular protozoon parasites of the genus Trypanosoma. Two subspecies...
9.
Bettiol E, Samanovic M, Murkin A, Raper J, Buckner F, Rodriguez A
PLoS Negl Trop Dis . 2009 Feb; 3(2):e384. PMID: 19238193
The development of new drugs against Chagas disease is a priority since the currently available medicines have toxic effects, partial efficacy and are targeted against the acute phase of disease....
10.
Samanovic M, Molina-Portela M, Chessler A, Burleigh B, Raper J
PLoS Pathog . 2009 Jan; 5(1):e1000276. PMID: 19165337
Innate immunity is the first line of defense against invading microorganisms. Trypanosome Lytic Factor (TLF) is a minor sub-fraction of human high-density lipoprotein that provides innate immunity by completely protecting...